Bristol Myers' blood cancer cell therapy succeeds in…
0 reactions
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial
\- Trial enrolls advanced multiple myeloma patients after four prior treatment classes fail
\- Single-infusion therapy engineers patients' immune cells to target GPRC5D protein
\- Bristol Myers says safety matches expectations for CAR-T and GPRC5D therapies
The drugmaker did not release specific numerical data, it said the results were statistically significant and clinically meaningful and that full findings will be presented at an upcoming medical meeting.
**Multiple myeloma is a cancer that forms in plasma cells, a type of white blood cell.**
An estimated 36,000 new cases and nearly 11,000 deaths from the disease are expected in the United States this year, according to the American Cancer Society.
#news #inspiration
\- Trial enrolls advanced multiple myeloma patients after four prior treatment classes fail
\- Single-infusion therapy engineers patients' immune cells to target GPRC5D protein
\- Bristol Myers says safety matches expectations for CAR-T and GPRC5D therapies
The drugmaker did not release specific numerical data, it said the results were statistically significant and clinically meaningful and that full findings will be presented at an upcoming medical meeting.
**Multiple myeloma is a cancer that forms in plasma cells, a type of white blood cell.**
An estimated 36,000 new cases and nearly 11,000 deaths from the disease are expected in the United States this year, according to the American Cancer Society.
#news #inspiration
| 0 mlx | |
| 1 | |
| 0 |